Zydus Lifesciences [ZYDUSLIFE] vs Torrent [TORNTPHARM] Detailed Stock Comparison

Zydus Lifesciences Ltd.

NSE
Loading...

Torrent Pharmaceuticals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Zydus Lifesciences Ltd. wins in 9 metrics, Torrent Pharmaceuticals Ltd. wins in 11 metrics, with 0 ties. Torrent Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Zydus Lifesciences Ltd. Torrent Pharmaceuticals Ltd. Better
P/E Ratio (TTM) 18.90 61.35 Zydus Lifesciences Ltd.
Price-to-Book Ratio 3.69 16.50 Zydus Lifesciences Ltd.
Debt-to-Equity Ratio 34.31 33.40 Torrent Pharmaceuticals Ltd.
PEG Ratio 1.32 2.35 Zydus Lifesciences Ltd.
EV/EBITDA 13.55 34.44 Zydus Lifesciences Ltd.
Profit Margin (TTM) 18.93% 17.83% Zydus Lifesciences Ltd.
Operating Margin (TTM) 18.83% 26.70% Torrent Pharmaceuticals Ltd.
EBITDA Margin (TTM) 18.83% 26.70% Torrent Pharmaceuticals Ltd.
Return on Equity 17.17% 25.18% Torrent Pharmaceuticals Ltd.
Return on Assets (TTM) 12.16% 12.75% Torrent Pharmaceuticals Ltd.
Free Cash Flow (TTM) $50.64B $19.73B Zydus Lifesciences Ltd.
Dividend Yield 1.44% 0.83% Zydus Lifesciences Ltd.
1-Year Return 15.88% 38.94% Torrent Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 3.58 10.94 Zydus Lifesciences Ltd.
Enterprise Value $986.42B $1,413.15B Torrent Pharmaceuticals Ltd.
EV/Revenue Ratio 3.78 11.09 Zydus Lifesciences Ltd.
Gross Profit Margin (TTM) 72.92% 75.42% Torrent Pharmaceuticals Ltd.
Revenue per Share (TTM) $259 $376 Torrent Pharmaceuticals Ltd.
Earnings per Share (Diluted) $49.06 $67.11 Torrent Pharmaceuticals Ltd.
Beta (Stock Volatility) 0.39 0.19 Torrent Pharmaceuticals Ltd.

Zydus Lifesciences Ltd. vs Torrent Pharmaceuticals Ltd. Stock Performance Analysis

Loading Price Chart...

ZYDUSLIFE
TORNTPHARM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Zydus Lifesciences Ltd.-0.16%-0.07%19.50%18.90%14.38%17.84%
Torrent Pharmaceuticals Ltd.1.17%-3.01%1.55%-1.17%15.82%12.20%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Zydus Lifesciences Ltd.15.88%108.05%69.32%237.26%499.29%1,405.38%
Torrent Pharmaceuticals Ltd.38.94%148.15%213.76%538.41%2,889.56%8,320.77%

Performance & Financial Health Analysis: Zydus Lifesciences Ltd. vs Torrent Pharmaceuticals Ltd.

MetricZYDUSLIFETORNTPHARM
Market Information
Market Cap i₹933.18B₹1.39T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i625,827393,915
90 Day Avg. Volume i651,634399,129
Last Close₹1,076.60₹4,368.50
52 Week Range₹835.50 - ₹1,115.50₹3,108.80 - ₹4,712.90
% from 52W High-3.49%-7.31%
All-Time High₹1,324.30 (Aug 05, 2024)₹4,712.90 (May 25, 2026)
% from All-Time High-18.70%-7.31%
Growth Metrics
Quarterly Revenue Growth0.30%0.18%
Quarterly Earnings Growth0.02%0.26%
Financial Health
Profit Margin (TTM) i0.19%0.18%
Operating Margin (TTM) i0.19%0.27%
Return on Equity (TTM) i0.17%0.25%
Debt to Equity (MRQ) i34.3133.40
Cash & Liquidity
Book Value per Share (MRQ)₹251.49₹249.47
Cash per Share (MRQ)₹70.27₹23.47
Operating Cash Flow (TTM) i₹76.54B₹27.02B
Levered Free Cash Flow (TTM) i₹45.26B₹19.11B
Dividends
Last 12-Month Dividend Yield i1.44%0.83%
Last 12-Month Dividend i₹14.00₹35.00

Valuation & Enterprise Metrics Analysis: Zydus Lifesciences Ltd. vs Torrent Pharmaceuticals Ltd.

MetricZYDUSLIFE (Apr 26, 2026)TORNTPHARM (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i18.9061.35
Forward P/E i22.1863.92
PEG Ratio i1.322.35
Price to Sales (TTM) i3.5810.94
Price to Book (MRQ) i3.6916.50
Market Capitalization
Market Capitalization i₹933.18B₹1.39T
Enterprise Value i₹986.42B₹1.41T
Enterprise Value Metrics
Enterprise to Revenue i3.7811.09
Enterprise to EBITDA i13.5534.44
Risk & Other Metrics
Beta i0.390.19
Book Value per Share (MRQ) i₹251.49₹249.47

Financial Statements Comparison: Zydus Lifesciences Ltd. vs Torrent Pharmaceuticals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricZYDUSLIFE (2025)TORNTPHARM (2025)
Revenue/Sales i225.74B113.17B
Cost of Goods Sold i66.66B28.84B
COGS % of Revenue i29.5%25.5%
Gross Profit i159.07B84.33B
Gross Margin i70.5%74.5%
Research & Development i1.89B304.20M
Operating Income (EBIT) i59.79B29.26B
Operating Margin i26.5%25.9%
EBITDA i71.13B37.25B
EBITDA Margin i31.5%32.9%
Pre-Tax Income i60.27B26.73B
Pre-Tax Income % of Revenue i26.7%23.6%
Income Tax i14.12B7.62B
Income Tax % of Revenue i6.3%6.7%
Net Income (Profit) i46.73B19.11B
Profit Margin i20.7%16.9%

Balance Sheet & Liquidity Metrics

MetricZYDUSLIFE (2025)TORNTPHARM (2025)
Cash & Equivalents i8.27B5.73B
Total Current Assets i170.46B56.23B
Total Current Assets % of Revenue i75.5%49.7%
Total Current Liabilities i90.42B47.17B
Total Current Liabilities % of Revenue i40.1%41.7%
Long-Term Debt i321.00M13.38B
Long-Term Debt % of Revenue i0.1%11.8%
Total Shareholders Equity i263.58B75.91B
Retained Earnings i245.62BN/A
Retained Earnings % of Revenue i108.8%0.0%
Property, Plant & Equipment i60.42B2.99B

Cash Flow Statement Comparison

MetricZYDUSLIFE (2025)TORNTPHARM (2025)
Operating Cash Flow i76.54B27.02B
Operating Cash Flow % of Revenue i33.9%23.9%
Capital Expenditures i-16.61B-5.94B
Free Cash Flow i50.64B19.73B
FCF Margin i22.4%17.4%
Debt Repayment i0-9.26B
Common Stock Repurchase i0N/A

Short Interest & Institutional Ownership Analysis

MetricZYDUSLIFETORNTPHARM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i1.01B338.45M
Float Shares i249.47M103.94M
% Held by Insiders i75.17%71.13%
% Held by Institutions i13.76%14.81%
% Held by Public i11.07%14.06%

Dividend Analysis & Yield Comparison: Zydus Lifesciences Ltd. vs Torrent Pharmaceuticals Ltd.

MetricZYDUSLIFETORNTPHARM
Last 12-Month Dividend i₹14.00₹35.00
Last 12-Month Dividend Yield i1.44%0.83%
3-Year Avg Annual Dividend i₹9.50₹32.33
3-Year Avg Dividend Yield i0.79%0.52%
3-Year Total Dividends i₹28.50₹97.00
Ex-Dividend DateJul 25, 2025Feb 18, 2026